← FDA DRUG APPROVALS

FDA ANDA · ANDA080850

LIDOCAINE HYDROCHLORIDE

Sponsor: AM REGENT

APPLICATION
ANDA080850
TYPE
ANDA
ORIGINAL APPROVAL
1972-06-23
LATEST ACTION
2010-04-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

LIDOCAINE HYDROCHLORIDEDiscontinued
LIDOCAINE HYDROCHLORIDE 1% · INJECTABLE · INJECTION

Approval history

2010-04-09Labeling · Supplement 29AP
2010-02-26Labeling · Supplement 28AP
2000-10-31Labeling · Supplement 22AP
1998-08-03Manufacturing (CMC) · Supplement 20AP
1998-08-03Manufacturing (CMC) · Supplement 19AP
1998-08-03Manufacturing (CMC) · Supplement 21AP
1993-06-24Manufacturing (CMC) · Supplement 18AP
1992-04-06Manufacturing (CMC) · Supplement 16AP
1992-04-06Manufacturing (CMC) · Supplement 15AP
1991-10-11Labeling · Supplement 17AP
1986-02-14Manufacturing (CMC) · Supplement 12AP
1986-02-14Manufacturing (CMC) · Supplement 13AP
1982-07-21Manufacturing (CMC) · Supplement 7AP
1972-06-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →